News 12.02.2025 Switzerland – 12 February 2025 – CUTISS AG, a life sciences company at the forefront of tissue engineering therapy and regenerative medicine, announced positive long-term efficacy and safety readout in the Phase 2 clinical trials of denovoSkin™ in reconstructive surgery as well as in burns treatment. The data reaffirm the role of...
News 06.02.2025 Schlieren-based medical device company Hemotune AG has received dual certification for its blood purification process. According to a press release, the company has received ISO 13485:2016 certification for both sterile and non-sterile medical devices and nanoparticles for blood purification. ISO 13485 is the internationally recognized standard for quality management systems in...
News 03.02.2025 Photonic Integrated Circuits (PICs) are rapidly transforming industries such as telecom, AI, datacom, and space—just as silicon chips revolutionized computing decades ago. However, the industry faces a major bottleneck: conventional semiconductor-based PICs have reached their performance limits, struggling to keep up with growing demands for speed and energy efficiency. The...
News 15.01.2025 January 14, 2025 - Zurich, Switzerland InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, is proud to announce that Chief Scientific Officer, Dr. Madhu Nag, has been appointed as a member of the Society for Laboratory Automation and Screening (SLAS) Board of Directors, serving a three-year term starting...
News 13.01.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a clinical-stage...